Abstract
Purpose. The purpose of this study was to determine the effect of food on the pharmacokinetics of zalcitabine in HIV-positive patients.
Methods. Twenty patients received single oral 1.5 mg doses of zalcitabine with and without a standard breakfast in an open-label, randomized crossover study with at least a one week washout period between treatments. Serial blood and urine samples were collected over 24 hours and assayed for zalcitabine by a modified GC/MS method.
Results. Administration with food delayed and prolonged absorption resulting in a decrease of approximately 39% in maximal plasma concentrations compared to dosing under fasting conditions. Comparison of plasma AUC values indicated a small (14%) reduction in bioavailability when given with food. Approximately 59% and 45% of the dose were excreted unchanged in the urine under fasting and fed conditions, respectively.
Conclusions. The results of this study show that the administration of zalcitabine with food results in a mild reduction in bioavailability. Although these changes are not expected to be of clinical importance, further studies must be conducted for confirmation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
L. E. Gustavson, E. K. Fukuda, F. R. Rubio and A. W. Dunton. A pilot study of the bioavailability and pharmacokinetics of 2′,3′-dideoxycytidine in patients with AIDS or AIDS-related complex. J. Acquir. Immune Defic. Syndr. 3:28–31 (1990).
R. W. Klecker, J. M. Collins, R. C. Yarchoan, R. Thomas, N. McAtee, S. Broder and C. E. Myers. Pharmacokinetics of 2′,3′-dideoxycytidine in Patients with AIDS and Related Disorders. J Clin. Pharmacol. 28:837–842 (1988).
L. Nazareno, A. Holazo, S. Koss-Twardy, B. Min, D. Ritter, R. Limjuco and J. W. Massarella. Influence of diarrhea on the absorption of ddC in HIV + Patients. Pharmaceut. Res. 10(Suppl):S-344 (1993).
A. Melander. Influence of food on the bioavailability of drugs. Clin. Pharmacokinet. 3:337–351 (1978).
P. G. Welling. Interactions affecting drug absorption. Clin. Pharmacokinet. 9:404–434 (1984).
M. Ruhnke, F. E. Bauer, M. Seifert, M. Trautmann, H. Hille and P. Koeppe. Effects of standard breakfast on pharmacokinetics of oral zidovudine in patients with AIDS. Antimicrob. Ag. Chemother. 37(10):2153–2158 (1993).
J. D. Unadkat, A. C. Collier, S. S. Crosby, D. Cummings, K. E. Opheim and L. Corey. Pharmacokinetics of oral zidovudine (azidothymidine) in patients with AIDS when administered with and without a high-fat meal. AIDS. 4:229–232 (1990).
W. C. Shyu, C. A. Knupp, K. A. Pittmann, L. Dunkle and R. H. Barbhaiya. Food-induced reduction on bioavailability of didanosine. Clin. Pharmacol. Ther. 50:503–7 (1991).
G. A. Leveille, M. E. Zabik and K. J. Morgan. Nutrients in Food, The Nutrition Guild: Cambridge, MA 1983.
CDC Update: Universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus and other bloodborne pathogens in health-care settings. MMWR. 37:377–388 (1988).
F. R. Rubio, T. Crews, W. A. Garland and E. K. Fukuda. Quantitation of dideoxycytidine in human plasma by gas chromatography/mass spectrometry. Biomed. Environ. Mass Spectrom. 17:399–404 (1988).
A. Hedayat and K. Afsarinejad. Repeated measurements design, II. Ann. Stat. 6:619–628 (1978).
D. J. Schuirmann. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J. Pharmacokinet. Biopharm. 15:657–680 (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nazareno, L.A., Holazo, A.A., Limjuco, R. et al. The Effect of Food on Pharmacokinetics of Zalcitabine in HIV-Positive Patients. Pharm Res 12, 1462–1465 (1995). https://doi.org/10.1023/A:1016275118710
Issue Date:
DOI: https://doi.org/10.1023/A:1016275118710